{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:26:54Z","timestamp":1784215614333,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471003, 81770784"],"award-info":[{"award-number":["81471003, 81770784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Previous studies reported that various miRNAs participate in autoimmune diseases, but the potential regulatory mechanism of miRNAs in autoimmune thyroiditis (AIT) needs further exploration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to\u00a0further\u00a0verify that miR-326 contributes to AIT by regulating Th17\/Treg balance through Ets-1 using lentiviral gene delivery through tail vein and thyroid\u00a0injection in NOD.H-2<jats:sup>h4<\/jats:sup> mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>Five-week-old NOD.H-2<jats:sup>h4<\/jats:sup> mice were divided randomly into tail vein and thyroid injection groups, and each received either mmu-miR-326 sponge (LV-sponge) or lentiviral vector control. Mice were divided for tail vein injection: the therapeutic LV-ctrl, therapeutic LV-sponge, prophylactic LV-ctrl, and prophylactic LV-sponge groups. The control group was fed high-iodine water without vein injection. The thyroid infiltration of lymphocytes and serum TgAb value were investigated by thyroid hematoxylin and eosin (HE) staining and ELISA, respectively. Ets-1 and lymphocyte counts were measured by RT-PCR, western blotting, and flow cytometry. The thyroid CD4<jats:sup>+<\/jats:sup>IL-17a<jats:sup>+<\/jats:sup> cells and CD4<jats:sup>+<\/jats:sup>Ets-1<jats:sup>+<\/jats:sup> cells were detected by immunofluorescence, and the serum cytokines were tested by ELISA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the tail vein injection groups, the thyroid inflammatory score and serum TgAb titer were significantly lower in the LV-sponge groups than in the control and LV-ctrl groups while Ets-1 protein expression in mouse spleens was increased in the LV-sponge groups. Moreover, Th17\/Treg ratio declined in the LV-sponge group and decreased significantly in the prophylactic LV-sponge group (<jats:italic>P<\/jats:italic> = 0.036) tested by flow cytometry. Immunofluorescence showed that, in LV-sponge groups, CD4<jats:sup>+<\/jats:sup>IL-17a<jats:sup>+<\/jats:sup> cells were decreased significantly (<jats:italic>P<\/jats:italic> = 0.001), while CD4<jats:sup>+<\/jats:sup>Ets-1<jats:sup>+<\/jats:sup> cells were increased significantly in the LV-sponge group (<jats:italic>P<\/jats:italic> = 0.029). The serum IL-17\/IL-10 was decreased significantly in the LV-sponge group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). In the thyroid injection groups, the thyroid inflammatory score and serum TgAb titer in the LV-sponge group decreased significantly compared with those in the LV-ctrl group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). In addition, in LV-sponge groups, CD4<jats:sup>+<\/jats:sup>IL-17a<jats:sup>+<\/jats:sup> cells were decreased, while CD4<jats:sup>+<\/jats:sup>Ets-1<jats:sup>+<\/jats:sup> cells were increased significantly in the inhibition group evaluated by immunofluorescence. Moreover, tail vein injection of LV-sponge resulted in much lower TgAb levels in thyroiditis compared with thyroid injection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MiR-326 targeted therapy may be a promising approach for AIT. In addition, tail vein injection may achieve a better intervention effect than thyroid injection.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.620916","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T07:05:42Z","timestamp":1622531142000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["In Vivo Inhibition of MicroRNA-326 in a NOD.H-2h4 Mouse Model of Autoimmune Thyroiditis"],"prefix":"10.3389","volume":"12","author":[{"given":"Na","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenling","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto Thyroiditis: Clinical and Diagnostic Criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.04.006","article-title":"Autoimmune Thyroiditis and ROS","volume":"7","author":"Burek","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1041","article-title":"More Than Adequate Iodine Intake may Increase Subclinical Hypothyroidism and Autoimmune Thyroiditis: A Cross-Sectional Study Based on Two Chinese Communities With Different Iodine Intake Levels","volume":"164","author":"Teng","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150712895","article-title":"Iodine Excess as an Environmental Risk Factor for Autoimmune Thyroid Disease","volume":"15","author":"Luo","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-008-0014-0","article-title":"Experimental Study on the Effects of Chronic Iodine Excess on Thyroid Function, Structure, and Autoimmunity in Autoimmune-Prone NOD.H-2h4 Mice","volume":"9","author":"Teng","year":"2009","journal-title":"Clin Exp Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2012.826","article-title":"Iodine Increases and Predicts Incidence of Thyroiditis in NOD Mice: Histopathological and Ultrastructural Study","volume":"5","author":"Vecchiatti","year":"2013","journal-title":"Exp Ther Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.009","article-title":"The Association of Other Autoimmune Diseases in Patients With Autoimmune Thyroiditis: Review of the Literature and Report of a Large Series of Patients","volume":"15","author":"Fallahi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and Regulatory T Cell Balance in Autoimmune and Inflammatory Diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22010134","article-title":"Therapeutic Potential of Targeting the Th17\/Treg Axis in Autoimmune Disorders","volume":"22","author":"Fasching","year":"2017","journal-title":"Mol (Basel Switzerland)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030730","article-title":"The Balance of Th17 Versus Treg Cells in Autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.11.026","article-title":"Autoimmune Thyroid Diseases and Th17\/Treg Lymphocytes","volume":"192","author":"Shao","year":"2018","journal-title":"Life Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.89","article-title":"The Regulation of the Treg\/Th17 Balance by Mesenchymal Stem Cells in Human Systemic Lupus Erythematosus","volume":"14","author":"Wang","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1159\/000484955","article-title":"Chloroquine Autophagic Inhibition Rebalances Th17\/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus","volume":"44","author":"An","year":"2017","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27180","article-title":"The Pathogenesis of Thyroid Autoimmune Diseases: New T Lymphocytes - Cytokines Circuits Beyond the Th1-Th2 Paradigm","volume":"234","author":"Li","year":"2019","journal-title":"J Cell Physiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1159\/000452541","article-title":"Imbalance of Th17\/Treg in Different Subtypes of Autoimmune Thyroid Diseases","volume":"40","author":"Li","year":"2016","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070994","article-title":"Ets-1 is a Negative Regulator of Th17 Differentiation","volume":"204","author":"Moisan","year":"2007","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-013-0263-4","article-title":"Expression of Ets-1 and FOXP3 mRNA in CD4(+)CD25 (+) T Regulatory Cells From Patients With Systemic Lupus Erythematosus","volume":"14","author":"Xiang","year":"2014","journal-title":"Clin Exp Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.178.3.793","article-title":"I-E+ Nonobese Diabetic Mice Develop Insulitis and Diabetes","volume":"178","author":"Podolin","year":"1993","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ai.2014.11.001","article-title":"Nod.H-2h4 Mice: An Important and Underutilized Animal Model of Autoimmune Thyroiditis and Sjogren\u2019s Syndrome","volume":"126","author":"Braley-Mullen","year":"2015","journal-title":"Adv Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.174.4014.1137","article-title":"Autoimmune Murine Thyroiditis Relation to Histocompatibility (H-2) Type","volume":"174","author":"Vladutiu","year":"1971","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1999.0272","article-title":"Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice","volume":"12","author":"Braley-Mullen","year":"1999","journal-title":"J Autoimmun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1465-4","article-title":"MicroRNA-326 Contributes to Autoimmune Thyroiditis by Targeting the Ets-1 Protein","volume":"59","author":"Zhao","year":"2018","journal-title":"Endocrine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jaut.2007.07.008","article-title":"CD4+CD25+ Naturally Occurring Regulatory T Cells and Not Lymphopenia Play a Role in the Pathogenesis of Iodide-Induced Autoimmune Thyroiditis in NOD-H2h4 Mice","volume":"29","author":"Nagayama","year":"2007","journal-title":"J Autoimmun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-0434","article-title":"T Helper Type 17 Immune Response Plays an Indispensable Role for Development of Iodine-Induced Autoimmune Thyroiditis in Nonobese diabetic-H2h4 Mice","volume":"150","author":"Horie","year":"2009","journal-title":"Endocrinology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15592294.2020.1827715","article-title":"microRNA27a-3p Mediates Reduction of the Wnt Antagonist sFRP-1 in Systemic Sclerosis","volume":"4","author":"Henderson","year":"2020","journal-title":"Epigenetics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97426","article-title":"MicroRNA-210 Overexpression Promotes Psoriasis-Like Inflammation by Inducing Th1 and Th17 Cell Differentiation","volume":"128","author":"Wu","year":"2018","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2014.04.069","article-title":"miR-326 and miR-26a, Two Potential Markers for Diagnosis of Relapse and Remission Phases in Patient With Relapsing-Remitting Multiple Sclerosis","volume":"544","author":"Honardoost","year":"2014","journal-title":"Gene"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1262","article-title":"Increased Expression of microRNA miR-326 in Type 1 Diabetic Patients With Ongoing Islet Autoimmunity","volume":"27","author":"Sebastiani","year":"2011","journal-title":"Diabetes\/metabolism Res Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0552","article-title":"Elevated MicroRNA-326 Levels Regulate the IL-23\/IL-23R\/Th17 Cell Axis in Hashimoto\u2019s Thyroiditis by Targeting a Disintegrin and Metalloprotease 17","volume":"30","author":"Liu","year":"2020","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2007.11.010","article-title":"Cd4 T Cells: Balancing the Coming and Going of Autoimmune-Mediated Inflammation in the CNS","volume":"22","author":"Dittel","year":"2008","journal-title":"Brain Behav Immun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013020130","article-title":"MicroRNA-155 Drives TH17 Immune Response and Tissue Injury in Experimental Crescentic GN","volume":"24","author":"Krebs","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrrheum.2017.49","article-title":"Immunometabolism in Early and Late Stages of Rheumatoid Arthritis","volume":"13","author":"Weyand","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2008.06582.x","article-title":"Molecular Aspects of Rheumatoid Arthritis: Role of Transcription Factors","volume":"275","author":"Okamoto","year":"2008","journal-title":"FEBS J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA Sponges: Competitive Inhibitors of Small RNAs in Mammalian Cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat Methods"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-016-0312-8","article-title":"Negative Correlation Between miR-326 and Ets-1 in Regulatory T Cells From New-Onset SLE Patients","volume":"39","author":"Sun","year":"2016","journal-title":"Inflammation"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1798","article-title":"MicroRNA miR-326 Regulates TH-17 Differentiation and is Associated With the Pathogenesis of Multiple Sclerosis","volume":"10","author":"Du","year":"2009","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12967-016-0917-6","article-title":"MicroRNA-142-5p Contributes to Hashimoto\u2019s Thyroiditis by Targeting CLDN1","volume":"14","author":"Zhu","year":"2016","journal-title":"J Trans Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2012.00102","article-title":"Mir141 Expression Differentiates Hashimoto Thyroiditis From PTC and Benign Thyrocytes in Irish Archival Thyroid Tissues","volume":"3","author":"Dorris","year":"2012","journal-title":"Front Endocrinol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.620916\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T07:05:45Z","timestamp":1622531145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.620916\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2021.620916"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.620916","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"article-number":"620916"}}